의료 예측 분석 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Healthcare Predictive Analytics Market Summary

The global healthcare predictive analytics market size was valued at USD 15.6 billion in 2025 and is projected to grow from USD 19.7 billion in 2026 to USD 49.3 billion by 2033, at a CAGR of 14.0% from 2026 to 2033. North America dominated the market, accounting for the largest share of 48.3% in 2025. The growth of the healthcare predictive analytics industry is attributed to the increasing adoption of big data and artificial intelligence (AI) in healthcare, the growing volume of patient data generated from electronic health records (EHRs) and wearable devices, the shift toward value-based care and population health management, and the rising demand for early disease prediction and personalized care.

Global Healthcare Predictive Analytics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare predictive analyticsmarket report based on application, end-use, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Operations Management
  • Demand Forecasting
  • Workforce Planning and Scheduling
  • Inpatient Scheduling
  • Outpatient Scheduling
• Financial
  • Revenue Cycle Management
  • Fraud Detection
  • Other Financial Applications
• Population Health
  • Population Risk Management
  • Patient Engagement
  • Population Therapy Management
  • Other Applications
• Clinical
  • Quality Benchmarking
  • Patient Care Enhancement
  • Clinical Outcome Analysis and Management
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Payers
• Providers
• Life science industry
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Application
  • 1.1.2. End use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Predictive Analytics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing Adoption of Big Data and AI in Healthcare
    • 3.2.1.2. Growing Volume of Patient Data from EHRs & Wearables
    • 3.2.1.3. Shift Toward Value-based Care And Population Health Management
    • 3.2.1.4. Demand For Early Disease Prediction And Personalized Care
    • 3.2.1.5. Increasing demand for early disease prediction and personalized medicine
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Data Privacy and Theft Issues
    • 3.2.2.2. Lack of Skilled Professionals
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Case Study Insights
• 3.4. Healthcare Predictive Analytics Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Technological landscape
    • 3.4.2.5. Environmental landscape
    • 3.4.2.6. Legal landscape

Chapter 4. Healthcare Predictive Analytics Market: Application Estimates & Trend Analysis

• 4.1. Application Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Healthcare Predictive Analytics Market by Application Outlook
• 4.4. Operations Management
  • 4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.4.2. Demand forecasting
    • 4.4.2.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.4.3. Workforce planning and scheduling
    • 4.4.3.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.4.4. Inpatient scheduling
    • 4.4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.4.5. Outpatient scheduling
    • 4.4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
• 4.5. Financial
  • 4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.5.2. Revenue Cycle Management (RCM)
    • 4.5.2.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.5.3. Fraud Detection
    • 4.5.3.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.5.4. Other financial applications
    • 4.5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
• 4.6. Population Health
  • 4.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6.2. Population Risk Management
    • 4.6.2.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6.3. Patient Engagement
    • 4.6.3.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6.4. Population therapy Management
    • 4.6.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6.5. Other application
    • 4.6.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
• 4.7. Clinical
  • 4.7.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.7.2. Quality Benchmarking
    • 4.7.2.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.7.3. Patient Care Enhancement
    • 4.7.3.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.7.4. Clinical Outcome Analysis and Management
    • 4.7.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Healthcare Predictive Analytics Market: End Use Estimates & Trend Analysis

• 5.1. Component Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global Healthcare Predictive Analytics Market by Component Outlook
• 5.4. Payer
  • 5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
• 5.5. Provider
  • 5.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
• 5.6. Life science industry
  • 5.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Healthcare Predictive Analytics Market: Regional Estimates & Trend Analysis, By Application, By End Use

• 6.1. Regional Market Dashboard
• 6.2. Regional Market: Key Takeaways
• 6.3. North America
  • 6.3.1. North America Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamic
    • 6.3.2.2. Regulatory framework
    • 6.3.2.3. Competitive insights
    • 6.3.2.4. U.S. Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamic
    • 6.3.3.2. Regulatory framework
    • 6.3.3.3. Competitive insights
    • 6.3.3.4. Canada Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamic
    • 6.3.4.2. Regulatory framework
    • 6.3.4.3. Competitive insights
    • 6.3.4.4. Mexico Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamic
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. Germany Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. UK
    • 6.4.3.1. Key country dynamic
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. UK Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamic
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. France Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamic
    • 6.4.5.2. Regulatory framework
    • 6.4.5.3. Competitive insights
    • 6.4.5.4. Italy Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamic
    • 6.4.6.2. Regulatory framework
    • 6.4.6.3. Competitive insights
    • 6.4.6.4. Spain Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Denmark
    • 6.4.7.1. Key country dynamic
    • 6.4.7.2. Regulatory framework
    • 6.4.7.3. Competitive insights
    • 6.4.7.4. Denmark Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key country dynamic
    • 6.4.8.2. Regulatory framework
    • 6.4.8.3. Competitive insights
    • 6.4.8.4. Sweden Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Norway
    • 6.4.9.1. Key country dynamic
    • 6.4.9.2. Regulatory framework
    • 6.4.9.3. Competitive insights
    • 6.4.9.4. Norway Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key country dynamic
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. Japan Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key country dynamic
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. China Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamic
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. India Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamic
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. South Korea Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Australia
    • 6.5.6.1. Key country dynamic
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Australia Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key country dynamic
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Thailand Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America Healthcare Predictive Analytics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamic
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. Brazil Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamic
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. Argentina Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. MEA
  • 6.7.1. MEA Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key country dynamic
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. South Africa Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key country dynamic
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Saudi Arabia Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamic
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive insights
    • 6.7.4.4. UAE Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamic
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive insights
    • 6.7.5.4. Kuwait Healthcare Predictive Analytics market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Company Market Position/Share Analysis, 2025
• 7.3. Company Evaluation Matrix
• 7.4. Company Profiles/Listing
  • 7.4.1. Merative (formerly IBM Watson Health)
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Verisk Analytics, Inc.
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. McKesson Corp.
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. SAS Institute, Inc.
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Oracle Corporation
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Veradigm
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Optum, Inc.
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. MedeAnalytics, Inc.
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Health Catalyst
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. IQVIA Inc.
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Inovalon
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. ClosedLoop
    • 7.4.12.1. Overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Cotiviti
    • 7.4.13.1. Overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Arcadia
    • 7.4.14.1. Overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives
  • 7.4.15. Innovaccer
    • 7.4.15.1. Overview
    • 7.4.15.2. Financial performance
    • 7.4.15.3. Product benchmarking
    • 7.4.15.4. Strategic initiatives